Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Cash from Investing Activities: 2009-2024

Historic Cash from Investing Activities for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to -$8.7 million.

  • Cross Country Healthcare's Cash from Investing Activities fell 9492.88% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.9 million, marking a year-over-year increase of 551.65%. This contributed to the annual value of -$8.7 million for FY2024, which is 3674.05% up from last year.
  • According to the latest figures from FY2024, Cross Country Healthcare's Cash from Investing Activities is -$8.7 million, which was up 3674.05% from -$13.8 million recorded in FY2023.
  • Cross Country Healthcare's 5-year Cash from Investing Activities high stood at -$4.6 million for FY2020, and its period low was -$43.9 million during FY2022.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$13.8 million (2023), whereas its average is -$21.0 million.
  • In the last 5 years, Cross Country Healthcare's Cash from Investing Activities tumbled by 63772.48% in 2021 and then soared by 6860.33% in 2023.
  • Annual analysis of 5 years shows Cross Country Healthcare's Cash from Investing Activities stood at -$4.6 million in 2020, then crashed by 637.72% to -$34.0 million in 2021, then fell by 28.87% to -$43.9 million in 2022, then soared by 68.6% to -$13.8 million in 2023, then surged by 36.74% to -$8.7 million in 2024.
  • Its Cash from Investing Activities was -$8.7 million in FY2024, compared to -$13.8 million in FY2023 and -$43.9 million in FY2022.